New Year’s Predictions From FDA Leadership Past And Present: GLP-1s, Mental Health, Big Data

 
• By Brenda Sandburg

Current and former commissioners note their positive expectations for the coming year and discuss efforts to standardize drug review and globalize filing of generics, while Janet Woodcock strikes a more sober tone on the ‘limitations of what both government and medicine can do.’

FDA chiefs
FDA Commissioner Robert Califf and fromer Commissioner Scott Gottlieb speak at CERSI Summit • Source: Screenshot from CERSI summit

More from US FDA

More from Agency Leadership